AstraZeneca (NASDAQ:AZN) said on Friday that its gastric cancer treatment, IMFINZI, demonstrated a statistically significant ...

An interval of fewer than 30 days between the last immunotherapy dose and the liver transplant increases the rejection risk ...

University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...

Scientists have uncovered the mechanism behind how aspirin could reduce the metastasis of some cancers by stimulating the ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

Plectin drives hepatocellular carcinoma progression and metastasis through cytoskeletal reorganization and oncogenic signaling, making it a promising therapeutic target for overcoming therapy ...

Treatment with thermal ablation was noninferior to surgical resection in small-size colorectal liver metastases, according to ...

Scientists have uncovered the mechanism behind how aspirin could reduce the metastasis of some cancers by stimulating the ...

Some patients are better candidates than others for histotripsy to treat liver tumors, but ultimately, this treatment still ...

Although histotripsy can successfully destroy tumors in the liver, longer-term data are still needed to see recurrence rates ...